US food benefits for the poor to be reduced as pandemic provisions end

Published Date: 02 Mar 2023

As the federal government ends pre-approved benefits during the early stages of the COVID-19 pandemic, low-income Americans could receive less food assistance or lose their eligibility altogether.

Read Full News

Latest News

How to Predict Iron Therapy Response in IBD

Hepcidin and ferritin-based indices help identify patients with active inflammatory bowel disease who are less likely to respond to iron therapy.

‘A Tiny Blueberry’: How Ingestible Sensors Keep Shrinking

A new thermometer is powerful, accurate, and easily swallowed even by children. Inside the push to make the perfectly sized, perfectly powered ingestible device.

Anxiety May Undermine Treatment Response in Some GERD Cases

Higher anxiety is linked to poorer response to proton pump inhibitor treatment among patients with gastroesophageal reflux disease.

Older Adults Have Worse Lower GI Bleeding Outcomes

Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.

Vaccine to Prevent Pancreatic Cancer Shows Early Promise

The vaccine spurs a lasting immune response in people at a high risk for pancreatic cancer. Whether it staves off the disease remains to be seen.

Durvalumab Tied to Extended Biliary Tract Cancer OS Benefit

Researchers examine 4-year outcomes of the phase 3 TOPAZ-1 study.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Latest News

Hepcidin and ferritin-based indices help identify patients with active inflammatory bowel disease who are less likely to respond to iron therapy.

A new thermometer is powerful, accurate, and easily swallowed even by children. Inside the push to make the perfectly sized, perfectly powered ingestible device.

Higher anxiety is linked to poorer response to proton pump inhibitor treatment among patients with gastroesophageal reflux disease.

Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.

The vaccine spurs a lasting immune response in people at a high risk for pancreatic cancer. Whether it staves off the disease remains to be seen.

Researchers examine 4-year outcomes of the phase 3 TOPAZ-1 study.

News All Time

Danish Duo's Maverick African Research Finds Its Moment in RFK Jr.'s Vaccine Policy

"They became more strident in saying that their findings were real," says one expert

FDA OKs First Treatment for Chronic Hepatitis D Infection

In phase III study, patients taking bulevirtide had ALT normalization and steep drops in HDV RNA

Blood Test for Colon Cancer Screening Gets Guideline Backing

Updated ACS guidance suggests use in those who decline other options

Perfusion Preservation Strategy Boosts Liver Transplant Outcomes

Portal-venous hypothermic oxygenated perfusion reduced incidence of early allograft dysfunction

GLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI Bleeding

News and commentary from the world of gastroenterology and hepatology

Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

Findings "will change the landscape" of treatment, researcher says

TIPS Was Tops for Refractory Hydrothorax in Cirrhosis

Majority of patients who received TIPS had a complete clinical response

Enhanced MRI Tops Ultrasound in Catching Early Liver Cancer

MRI approach also led to fewer false referrals

Multicancer Early Detection Test Fails to Reduce Cancers Detected at Late Stages

However, an increase in the detection of stage I/II cancers was observed

'A Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

RASolute 302 findings herald a new standard of care in previously treated patients

Albumin 5% Cut Mortality Rates in Sudden Liver Failure With Other Organ Failure

Treatment may be an effective bridge to transplantation for acute-on-chronic liver failure

Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis

More than half of patients saw a biochemical response by 1 year with the novel oral agent

Non-Operative Treatment for CRC May Include Observation After Complete Response

No difference in disease-free, overall survival compared with 3 years of maintenance therapy

Targeted Combo Boosts PFS in BRAF-Mutant Metastatic Colorectal Cancer

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival

Adding Immunotherapy-Based Combo Boosts PFS in Unresectable Liver Cancer

But is the higher incidence of grade 3/4 adverse events "a worthwhile price to pay?" expert asks

Large Study Links GLP-1s to Lower Risk of Multiple Cancers

Patients taking the drugs for obesity had a 41% lower risk of related cancers

Recommended News For You

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

Recommended Articles For You

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders 

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances 

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management 

Immune Surveillance Screening for Early Cancer Risk Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

2.

Novel Agent for Chronic GVHD Wins FDA Approval

3.

Cancer mortality continuing to decline, says report

4.

Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.

5.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

1.

Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment

2.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

3.

Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy

4.

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook

5.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part XI

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

3.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

4.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

5.

Navigating the Complexities of Ph Negative ALL - Part IX

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot